• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by Moolec Science SA

    4/21/25 11:43:11 AM ET
    $MLEC
    Blank Checks
    Finance
    Get the next $MLEC alert in real time by email
    6-K 1 ea0238920-6k_moolec.htm REPORT OF FOREIGN PRIVATE ISSUER

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    Form 6-K

     

    Report of Foreign Private Issuer

    Pursuant to Rules 13a-16 or 15d-16 under

    the Securities Exchange Act of 1934

     

    For the month of April 2025

     

    Commission File Number: 001-41586

     

    MOOLEC SCIENCE SA

    (Exact name of Registrant as Specified in Its Charter)

     

    17, Boulevard F. W. Raiffeisen

    L-2411 Luxembourg,

    Grand Duchy of Luxembourg

    (Address of principal executive offices)

     

    Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

     

    Form 20-F  ☒         Form 40-F  ☐

     

     

     

     

     

     

    EXHIBIT LIST

     

    Exhibit No.   Description
    99.1   Press release of Moolec Science SA dated April 21, 2025.

     

    1

     

     

    SIGNATURE

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

      MOOLEC SCIENCE SA
      (Registrant)
         
    Dated: April 21, 2025 By: /s/ José López Lecube
      Name:  José López Lecube
      Title: Chief Financial Officer

     

    2

     

    Get the next $MLEC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MLEC

    DatePrice TargetRatingAnalyst
    9/27/2023$5.00Buy
    ROTH MKM
    More analyst ratings

    $MLEC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Moolec Has Received USDA Approval for the First Genetically Modified Pea in History

      LUXEMBOURG / ACCESSWIRE / October 16, 2024 / Moolec Science SA (NASDAQ:MLEC) ("the Company"), a leader in Molecular Farming technology, announced today that the U.S. Department of Agriculture's ("USDA") Animal and Plant Health Inspection Service ("APHIS") has completed its Regulatory Status Review ("RSR") for the Company's genetically engineered ("GE") peas which produce iron through bovine meat proteins. This is the third regulatory clearance from USDA-APHIS achieved by Moolec in an 18-month window, alongside its genetically engineered safflower and soybean for GLASO™ and Piggy Sooy™ products, respectively. Access the official USDA-APHIS publication here. "With USDA approval for our GE pe

      10/16/24 6:00:00 AM ET
      $MLEC
      Blank Checks
      Finance
    • Moolec Science Presents Fiscal Year 2024 Annual Business Update

      LUXEMBOURG / ACCESSWIRE / October 2, 2024 / Moolec Science SA (NASDAQ:MLEC) ("The Company"; "Moolec"), a science-based food ingredient company focused on producing animal proteins and nutritional oils in plants, today reported its Business Update for the fourth quarter of Fiscal Year 2024 ended June 30, 2024. Moolec Science Logo The main highlights of Moolec's fourth quarter are as follows:GLASO™: The Company announced an offtake agreement with a major global CPG food and pet food company and an R&D collaboration agreement with Bunge. Also, Moolec made significant advancements in both upstream and downstream processes.Piggy Sooy™: Field trials in three different US locations continue on sch

      10/2/24 6:00:00 AM ET
      $MLEC
      Blank Checks
      Finance
    • Moolec Science to Host Fourth Quarter Fiscal Year 2024 Business Update Conference Call

      LUXEMBOURG / ACCESSWIRE / September 25, 2024 / Moolec Science SA (NASDAQ:MLEC)("The Company"; "Moolec"), a science-based food ingredient company focused on producing animal proteins and nutritional oils in plants, announced today that it will release its Business Update for the Fourth Quarter and Full Fiscal Year 2024 on Wednesday, October 2, 2024, before the market opens.Moolec Sciences Logo Moolec's Chief Executive Officer Gastón Paladini, Chief Financial Officer José López Lecube, and Chief Science Officer Amit Dhingra, will host a live Conference Call, followed by a question-and-answer session, on Wednesday, October 2, 2024 at 08:30am ET.The Conference Call will be accompanied by a pr

      9/25/24 6:00:00 AM ET
      $MLEC
      Blank Checks
      Finance

    $MLEC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • ROTH MKM initiated coverage on Moolec Science with a new price target

      ROTH MKM initiated coverage of Moolec Science with a rating of Buy and set a new price target of $5.00

      9/27/23 7:44:02 AM ET
      $MLEC
      Blank Checks
      Finance

    $MLEC
    SEC Filings

    See more
    • SEC Form 6-K filed by Moolec Science SA

      6-K - Moolec Science SA (0001937737) (Filer)

      5/13/25 11:33:56 AM ET
      $MLEC
      Blank Checks
      Finance
    • SEC Form 6-K filed by Moolec Science SA

      6-K - Moolec Science SA (0001937737) (Filer)

      4/29/25 5:29:32 PM ET
      $MLEC
      Blank Checks
      Finance
    • SEC Form 6-K filed by Moolec Science SA

      6-K - Moolec Science SA (0001937737) (Filer)

      4/22/25 8:30:49 PM ET
      $MLEC
      Blank Checks
      Finance

    $MLEC
    Financials

    Live finance-specific insights

    See more
    • Moolec Science Presents Fiscal Year 2024 Annual Business Update

      LUXEMBOURG / ACCESSWIRE / October 2, 2024 / Moolec Science SA (NASDAQ:MLEC) ("The Company"; "Moolec"), a science-based food ingredient company focused on producing animal proteins and nutritional oils in plants, today reported its Business Update for the fourth quarter of Fiscal Year 2024 ended June 30, 2024. Moolec Science Logo The main highlights of Moolec's fourth quarter are as follows:GLASO™: The Company announced an offtake agreement with a major global CPG food and pet food company and an R&D collaboration agreement with Bunge. Also, Moolec made significant advancements in both upstream and downstream processes.Piggy Sooy™: Field trials in three different US locations continue on sch

      10/2/24 6:00:00 AM ET
      $MLEC
      Blank Checks
      Finance
    • Moolec Science to Host Fourth Quarter Fiscal Year 2024 Business Update Conference Call

      LUXEMBOURG / ACCESSWIRE / September 25, 2024 / Moolec Science SA (NASDAQ:MLEC)("The Company"; "Moolec"), a science-based food ingredient company focused on producing animal proteins and nutritional oils in plants, announced today that it will release its Business Update for the Fourth Quarter and Full Fiscal Year 2024 on Wednesday, October 2, 2024, before the market opens.Moolec Sciences Logo Moolec's Chief Executive Officer Gastón Paladini, Chief Financial Officer José López Lecube, and Chief Science Officer Amit Dhingra, will host a live Conference Call, followed by a question-and-answer session, on Wednesday, October 2, 2024 at 08:30am ET.The Conference Call will be accompanied by a pr

      9/25/24 6:00:00 AM ET
      $MLEC
      Blank Checks
      Finance
    • Moolec Science to Host Third Quarter Fiscal Year 2024 Business Update Conference Call

      LUXEMBOURG / ACCESSWIRE / May 23, 2024 / Moolec Science SA (NASDAQ:MLEC)("Company"; "Moolec"), a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming, announced today that it will release its Business Update for the Third Quarter Fiscal Year 2024 on Thursday, May 30, 2024, before the market opens. Moolec Logo Moolec Science Logo Moolec's Chief Executive Officer Gastón Paladini, Chief Financial Officer José López Lecube, and Chief Science Officer Amit Dhingra, will host a live Conference Call, followed by a question-and-answer session, on Thursday, May 30, 2024, at 08:30 a.m. ET.The Conference Call will be accompanied by a presentation

      5/23/24 7:00:00 AM ET
      $MLEC
      Blank Checks
      Finance

    $MLEC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D filed by Moolec Science SA

      SC 13D - Moolec Science SA (0001937737) (Subject)

      4/17/24 5:14:28 PM ET
      $MLEC
      Blank Checks
      Finance
    • SEC Form SC 13D/A filed by Moolec Science SA (Amendment)

      SC 13D/A - Moolec Science SA (0001937737) (Subject)

      4/10/24 9:39:03 PM ET
      $MLEC
      Blank Checks
      Finance